ORLANDO, Fla. — The topical Janus tyrosine kinase (JAK) 1/2 inhibitor ruxolitinib improved itching and nodules in patients with prurigo nodularis (PN) significantly better than a vehicle within a week ...

San Diego — Nemolizumab, the first-in-class inhibitor of interleukin-31 (IL-31), a neuroimmune cytokine linked to the promotion of pruritis and inflammation, continues to show good efficacy and safety ...

Prurigo nodularis is an extremely itchy skin condition. It causes a rash that often includes hard lumps called nodules. You might also hear it called nodular prurigo. Doctors don’t know exactly what ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SWX:GALD) today announced that full results from the phase III OLYMPIA 1 trial, a 24-week study which evaluated the efficacy and safety of nemolizumab ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced that the New England Journal of Medicine has published full results from the phase III OLYMPIA 2 trial evaluating the efficacy and safety of ...

Prurigo nodularis is a disabling chronic skin condition characterized by severely itchy, crusty, firm papules and nodules that often occur on the arms and legs, but can appear diffusely on the body.

Prurigo nodularis (PN) is a chronic inflammatory skin condition characterized by firm, itchy, and often painful bumps (nodules) on the skin. It typically begins with intense itchiness, which can be ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Currently, there are no approved topicals for the ...

Newark, New Castle, USA, April 19, 2023 (GLOBE NEWSWIRE) -- According to a recent Growth Plus Reports assessment, the Prurigo Nodularis Treatment Market is estimated to reach US$ 3.40 billion by 2031, ...

The itch can be so intense that it causes an uncontrollable urge to scratch and rub, which causes more itching and inflammation. After about six weeks, hard (not pus-filled) nodules appear where the ...